Sign In

Login

Password

Forgot Password ? Sign Up

تجربة الإستروجين في الجلطات الدموية الوريدية (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "تجربة الإستروجين في الجلطات الدموية الوريدية" in Arabic language version.

refsWebsite
Global rank Arabic rank
18nih.gov
4th place
6th place
16doi.org
2nd place
5th place
1web.archive.org
1st place
1st place
1imrpress.com
low place
low place

doi.org

  • "Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)". Thromb Haemost. ج. 84 ع. 6: 961–7. ديسمبر 2000. DOI:10.1055/s-0037-1614156. PMID:11154141.
  • "The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial". Thromb Haemost. ج. 85 ع. 5: 775–81. مايو 2001. DOI:10.1055/s-0037-1615717. PMID:11372667.
  • "Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review". Fertil Steril. ج. 90 ع. 3: 642–72. سبتمبر 2008. DOI:10.1016/j.fertnstert.2007.07.1298. PMID:17923128.
  • "Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis". Thromb Res. ج. 168: 83–95. أغسطس 2018. DOI:10.1016/j.thromres.2018.06.014. PMID:29936403.
  • "Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis". Climacteric. ج. 21 ع. 4: 341–345. أغسطس 2018. DOI:10.1080/13697137.2018.1446931. PMID:29570359.
  • "The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review". Hum Reprod Update. ج. 25 ع. 2: 257–271. مارس 2019. DOI:10.1093/humupd/dmy039. PMID:30508190.
  • "Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases". BMJ. ج. 364: k4810. يناير 2019. DOI:10.1136/bmj.k4810. PMC:6326068. PMID:30626577.
  • "Hormone therapy and recurrence of venous thromboembolism among postmenopausal women". Menopause. ج. 18 ع. 5: 488–93. مايو 2011. DOI:10.1097/gme.0b013e3181f9f7c3. PMID:21178641.
  • "Risk of venous thromboembolism by route of administration of estrogen". Menopause. ج. 18 ع. 5: 469–70. مايو 2011. DOI:10.1097/gme.0b013e318211745b. PMID:21407136.
  • "Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women". Curr Opin Hematol. ج. 17 ع. 5: 457–63. سبتمبر 2010. DOI:10.1097/MOH.0b013e32833c07bc. PMID:20601871.
  • "Hormone therapy and venous thromboembolism among postmenopausal women". Front Horm Res. Frontiers of Hormone Research. ج. 43: 21–32. 2014. DOI:10.1159/000360554. ISBN:978-3-318-02673-3. PMID:24943295.
  • "What if the Women's Health Initiative had used transdermal estradiol and oral progesterone instead?". Menopause. ج. 21 ع. 7: 769–83. يوليو 2014. DOI:10.1097/GME.0000000000000169. PMID:24398406.
  • "EMAS position statement: Managing menopausal women with a personal or family history of VTE". Maturitas. ج. 69 ع. 2: 195–8. يونيو 2011. DOI:10.1016/j.maturitas.2011.03.011. PMID:21489728.
  • "Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline". J Clin Endocrinol Metab. ج. 100 ع. 11: 3975–4011. نوفمبر 2015. DOI:10.1210/jc.2015-2236. PMID:26444994.
  • "American Association of Clinical Endocrinologists and American College of Endocrinology position statement on menopause–2017 update". Endocr Pract. ج. 23 ع. 7: 869–880. يوليو 2017. DOI:10.4158/EP171828.PS. PMID:28703650.
  • The NAMS 2017 Hormone Therapy Position Statement Advisory Panel (يوليو 2017). "The 2017 hormone therapy position statement of The North American Menopause Society". Menopause. ج. 24 ع. 7: 728–753. DOI:10.1097/GME.0000000000000921. PMID:28650869. {{استشهاد بدورية محكمة}}: |الأخير= باسم عام (مساعدة)صيانة الاستشهاد: أسماء عددية: قائمة المؤلفين (link)

imrpress.com

ceog.imrpress.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • "Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)". Thromb Haemost. ج. 84 ع. 6: 961–7. ديسمبر 2000. DOI:10.1055/s-0037-1614156. PMID:11154141.
  • "The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial". Thromb Haemost. ج. 85 ع. 5: 775–81. مايو 2001. DOI:10.1055/s-0037-1615717. PMID:11372667.
  • "Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review". Fertil Steril. ج. 90 ع. 3: 642–72. سبتمبر 2008. DOI:10.1016/j.fertnstert.2007.07.1298. PMID:17923128.
  • "Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis". Thromb Res. ج. 168: 83–95. أغسطس 2018. DOI:10.1016/j.thromres.2018.06.014. PMID:29936403.
  • "Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis". Climacteric. ج. 21 ع. 4: 341–345. أغسطس 2018. DOI:10.1080/13697137.2018.1446931. PMID:29570359.
  • "The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review". Hum Reprod Update. ج. 25 ع. 2: 257–271. مارس 2019. DOI:10.1093/humupd/dmy039. PMID:30508190.
  • "Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases". BMJ. ج. 364: k4810. يناير 2019. DOI:10.1136/bmj.k4810. PMC:6326068. PMID:30626577.
  • "Transdermal estrogen therapy effects on fibrinogen levels in women with a past history of venous thromboembolism: a pilot study". Clin Exp Obstet Gynecol. ج. 38 ع. 3: 232–5. 2011. PMID:21995153. مؤرشف من الأصل في 2022-02-07.
  • "Hormone therapy and recurrence of venous thromboembolism among postmenopausal women". Menopause. ج. 18 ع. 5: 488–93. مايو 2011. DOI:10.1097/gme.0b013e3181f9f7c3. PMID:21178641.
  • "Risk of venous thromboembolism by route of administration of estrogen". Menopause. ج. 18 ع. 5: 469–70. مايو 2011. DOI:10.1097/gme.0b013e318211745b. PMID:21407136.
  • "Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women". Curr Opin Hematol. ج. 17 ع. 5: 457–63. سبتمبر 2010. DOI:10.1097/MOH.0b013e32833c07bc. PMID:20601871.
  • "Hormone therapy and venous thromboembolism among postmenopausal women". Front Horm Res. Frontiers of Hormone Research. ج. 43: 21–32. 2014. DOI:10.1159/000360554. ISBN:978-3-318-02673-3. PMID:24943295.
  • "What if the Women's Health Initiative had used transdermal estradiol and oral progesterone instead?". Menopause. ج. 21 ع. 7: 769–83. يوليو 2014. DOI:10.1097/GME.0000000000000169. PMID:24398406.
  • "EMAS position statement: Managing menopausal women with a personal or family history of VTE". Maturitas. ج. 69 ع. 2: 195–8. يونيو 2011. DOI:10.1016/j.maturitas.2011.03.011. PMID:21489728.
  • "Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline". J Clin Endocrinol Metab. ج. 100 ع. 11: 3975–4011. نوفمبر 2015. DOI:10.1210/jc.2015-2236. PMID:26444994.
  • "American Association of Clinical Endocrinologists and American College of Endocrinology position statement on menopause–2017 update". Endocr Pract. ج. 23 ع. 7: 869–880. يوليو 2017. DOI:10.4158/EP171828.PS. PMID:28703650.
  • The NAMS 2017 Hormone Therapy Position Statement Advisory Panel (يوليو 2017). "The 2017 hormone therapy position statement of The North American Menopause Society". Menopause. ج. 24 ع. 7: 728–753. DOI:10.1097/GME.0000000000000921. PMID:28650869. {{استشهاد بدورية محكمة}}: |الأخير= باسم عام (مساعدة)صيانة الاستشهاد: أسماء عددية: قائمة المؤلفين (link)

ncbi.nlm.nih.gov

web.archive.org